Hideyuki Hasebe1, Kentaro Yoshida2, Masataka Iida3, Naoki Hatano3, Toshiro Muramatsu3, Kazutaka Aonuma4. 1. Division of Arrhythmology, Shizuoka Saiseikai General Hospital, Shizuoka, Japan. 2. Cardiovascular Division, Ibaraki Prefectural Central Hospital, Kasama, Japan; Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan,. Electronic address: kentaroyo@nifty.com. 3. Division of Clinical Engineering, Shizuoka Saiseikai General Hospital, Shizuoka, Japan. 4. Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Abstract
BACKGROUND: A left-to-right dominant frequency (DF) gradient commonly exists in paroxysmal atrial fibrillation (AF). AF initiated by right atrial (RA) ectopy (AF-RAE) is rare. OBJECTIVE: This study aimed to investigate characteristics of AF-RAE using pharmacological maneuvers and spectral analysis. METHODS: Seventy-nine consecutive patients referred for catheter ablation of paroxysmal AF were enrolled. Infusions of isoproterenol and adenosine triphosphate (ATP) were used to induce AF. Patients with AF-RAE and patients with AF initiated only by pulmonary vein (PV) ectopies were classified into the RA-ectopy group (n = 7[9%]) and PV-ectopy group (n = 32[41%]), respectively. ATP was also injected during ongoing AF to unmask the driver of AF. High RA, coronary sinus, and PV-left atrial junction electrograms and electrocardiogram lead V1 underwent spectral analyses. RESULTS: Patients in the RA-ectopy group were younger (51 ± 13 years vs 63 ± 7 years; P = .01) and more commonly had a family history of AF (71% vs 9%; P < .001) than patients in the PV-ectopy group. There was a baseline right-to-left DF gradient in the RA-ectopy group (PV-left atrial junction: 6.0 ± 0.4 Hz; coronary sinus: 5.7 ± 0.6 Hz; RA: 7.3 ± 0.8 Hz; P < .05) in contrast to a left-to-right DF gradient in the PV-ectopy group (5.9 ± 0.8, 5.3 ± 0.7, 5.2 ± 0.8 Hz; P < .01). ATP injection predominantly increased the DF of the high RA in the RA-ectopy group and augmented a right-to-left DF gradient (7.9 ± 1.8, 7.6 ± 1.0, 10.7 ± 0.7 Hz; P < .001), whereas it augmented a left-to-right DF gradient in the PV-ectopy group (7.9 ± 1.0, 6.4 ± 0.5, 6.6 ± 1.2 Hz; P < .05). CONCLUSION: A rare type of paroxysmal AF initiated by RA ectopy may be maintained by a reentrant driver localized in the RA (so-called RA fibrillation).
BACKGROUND: A left-to-right dominant frequency (DF) gradient commonly exists in paroxysmal atrial fibrillation (AF). AF initiated by right atrial (RA) ectopy (AF-RAE) is rare. OBJECTIVE: This study aimed to investigate characteristics of AF-RAE using pharmacological maneuvers and spectral analysis. METHODS: Seventy-nine consecutive patients referred for catheter ablation of paroxysmal AF were enrolled. Infusions of isoproterenol and adenosine triphosphate (ATP) were used to induce AF. Patients with AF-RAE and patients with AF initiated only by pulmonary vein (PV) ectopies were classified into the RA-ectopy group (n = 7[9%]) and PV-ectopy group (n = 32[41%]), respectively. ATP was also injected during ongoing AF to unmask the driver of AF. High RA, coronary sinus, and PV-left atrial junction electrograms and electrocardiogram lead V1 underwent spectral analyses. RESULTS:Patients in the RA-ectopy group were younger (51 ± 13 years vs 63 ± 7 years; P = .01) and more commonly had a family history of AF (71% vs 9%; P < .001) than patients in the PV-ectopy group. There was a baseline right-to-left DF gradient in the RA-ectopy group (PV-left atrial junction: 6.0 ± 0.4 Hz; coronary sinus: 5.7 ± 0.6 Hz; RA: 7.3 ± 0.8 Hz; P < .05) in contrast to a left-to-right DF gradient in the PV-ectopy group (5.9 ± 0.8, 5.3 ± 0.7, 5.2 ± 0.8 Hz; P < .01). ATP injection predominantly increased the DF of the high RA in the RA-ectopy group and augmented a right-to-left DF gradient (7.9 ± 1.8, 7.6 ± 1.0, 10.7 ± 0.7 Hz; P < .001), whereas it augmented a left-to-right DF gradient in the PV-ectopy group (7.9 ± 1.0, 6.4 ± 0.5, 6.6 ± 1.2 Hz; P < .05). CONCLUSION: A rare type of paroxysmal AF initiated by RA ectopy may be maintained by a reentrant driver localized in the RA (so-called RA fibrillation).
Authors: Ning Li; Thomas A Csepe; Brian J Hansen; Lidiya V Sul; Anuradha Kalyanasundaram; Stanislav O Zakharkin; Jichao Zhao; Avirup Guha; David R Van Wagoner; Ahmet Kilic; Peter J Mohler; Paul M L Janssen; Brandon J Biesiadecki; John D Hummel; Raul Weiss; Vadim V Fedorov Journal: Circulation Date: 2016-07-26 Impact factor: 29.690
Authors: Aleksei V Mikhailov; Anuradha Kalyanasundaram; Ning Li; Shane S Scott; Esthela J Artiga; Megan M Subr; Jichao Zhao; Brian J Hansen; John D Hummel; Vadim V Fedorov Journal: J Mol Cell Cardiol Date: 2020-10-29 Impact factor: 5.000
Authors: Caroline H Roney; Steven E Williams; Hubert Cochet; Rahul K Mukherjee; Louisa O'Neill; Iain Sim; John Whitaker; Orod Razeghi; George J Klein; Edward J Vigmond; Mark O'Neill; Steven A Niederer Journal: Europace Date: 2018-11-01 Impact factor: 5.214
Authors: Gurpreet Singh Dhillon; Nikhil Ahluwalia; Shohreh Honarbakhsh; Adam Graham; Antonio Creta; Hakam Abbass; Anthony Chow; Mark J Earley; Pier D Lambiase; Richard J Schilling; Ross J Hunter Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240
Authors: Michelle L Munro; Isabelle van Hout; Hamish M Aitken-Buck; Ramanen Sugunesegran; Krishna Bhagwat; Philip J Davis; Regis R Lamberts; Sean Coffey; Christian Soeller; Peter P Jones Journal: Front Cell Dev Biol Date: 2021-02-25